Cushing's syndrome caused by short-term topical glucocorticoid use for erythrodermic psoriasis and development of adrenal insufficiency after glucocorticoid withdrawal

European Journal of Dermatology

Volumn 19, Issue 2, 2009, Pages 169-170

  Pelin, Selda ^a   Durmazlar, Kartal ^a   Oktay, Bilgen ^a   Eren, Cemile ^a   Eskioglu, Fatma ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOTROPIN; DEXAMETHASONE; ETRETIN; GLUCOCORTICOID; HYDROCORTISONE; MOMETASONE FUROATE; PREDNISOLONE;

ADRENAL INSUFFICIENCY; ADULT; ANTIBIOTIC THERAPY; CASE REPORT; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PSORIASIS; URINARY TRACT INFECTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENAL INSUFFICIENCY; ADULT; CUSHING SYNDROME; FEMALE; GLUCOCORTICOIDS; HUMANS; PSORIASIS;

EID: 65449164645     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2008.0584     Document Type: Letter

References (6)

1. Schocke H, Docke VVD, Asadullah K. Mechanism involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96: 23-43.
2. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Derrmatol 2006; 54: 1-15.
3. Augey F, Renaudier P, Nicolas JF. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol 2006; 16:669-673
4. Borzyskowski M, Grant DB, Wells RS. Cushing's syndrome induced by topical steroids used for the treatment of non-bullous ichthyosiform erythroderma. Clin Exp Dermatol 1976; 1: 337-342
5. Pershing LK, Silver BS, Krueger GG, Shah VP, Skelley JP. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharmacol Res 1992; 9: 45-51.
6. Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: A potential marker for glucocorticoid sensitivity, potency ana bioavailability. J Clin Endo-crinol Metab 2003; 88: 277-284.